SCHEMBL24330862

SCHEMBL24330862

CCNc1cccc(SNc2nc(O)cc(-c3c(C)cccc3C)n2)c1

nearest known ligand 0.31

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
F10 P00742 1/20 0.31
LCK P06239 1/20 0.30
HTR7 P34969 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24329987 0.87 PLK1 (0.35)
SCHEMBL24298907 0.79 PARP1 (0.38) LCK
SCHEMBL24299252 0.79 CYP1A2 (0.40)
SCHEMBL24325812 0.72 MAP4K1 (0.39) F10LCK
SCHEMBL24310515 0.71
SCHEMBL24326765 0.71 TDP1 (0.43) HTR7
SCHEMBL24331843 0.70 NR1H2 (0.34)
SCHEMBL22509298 0.67 CYP1A2 (0.40)
SCHEMBL24310313 0.66 SRC (0.30)
SCHEMBL24310507 0.65 AGTR1 (0.38)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022076626-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 WO disclosed